Alzheimer’s Drug lecanemab Showing Promising Results In Clinical Trials
A new investigational drug, from Eisai and Biogen, has shown promising results for slowing progression of cognitive decline during Phase...
Specialist Broking
A new investigational drug, from Eisai and Biogen, has shown promising results for slowing progression of cognitive decline during Phase...
Mass General Brigham suffered a net loss of $948m in Q3, a huge contrast to Q3 last year, which saw an $870m net gain.
The recent loss,...
As we have all seen there has been a widespread shortage in nursing staff caused by the COVID-19 pandemic. To help get things back on...
Following the FDA's recommendation that COVID-19 vaccine manufacturers continue to work on their booster products in order to counter new...
As the terrible situation in Ukraine continues, refugees are being offered relocation, training and employment from the US long-term care...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net